Country : Germany
Summary : Completion of a Non-exclusive Discount Agreement According to § 130a (8) Sgb V for the Active Substance Everolimus (exclusively Indication Breast Cancinoma), Atc L01xe10, for the Time 01.11.2021 - 31.10.2023
TPD Ref No : 57603822
Document Ref. No. : 472972-2021
Financier : Self Financed
Purchaser : View
Tender Details : View
Deadline : 05 Sep 2023
Documents : Download